Health Data Security in Clinical R&D: An International Security Blindspot?

Authors

  • Janie Gittleman ManTech International Corporation
  • Katherine Hasty Future Warfare
  • Steven Schachter Harvard Medical School
  • Daniel Payne ManTech International Corporation

DOI:

https://doi.org/10.31646/gbio.152

Keywords:

Health, Data Security, Cybersecurity, Surveillance, Clinical Research and Development

Author Biographies

Janie Gittleman, ManTech International Corporation

Dr. Janie L. Gittleman, Executive Director Global Health Innovation ManTech International, former Sr. Health Advisor to Defense Intelligence Agency Surgeon General & Director, and 23 yrs as an Occupational Epidemiologist with the Centers for Disease Control and Prevention (CDC), National Institute for Occupational Safety and Health.

Katherine Hasty, Future Warfare

Katherine Hasty, U.S. Air Force Veteran and Director, Future Warfare, Long Term Strategy Group

Steven Schachter, Harvard Medical School

Dr. Steven Schachter, Chief Academic Officer, Consortia for Improving Medicine with Innovation and Technology (CIMIT), Departments of Neurology Harvard Medical School, Beth Israel Deaconess Medical Center and Massachusetts General Hospital

Daniel Payne, ManTech International Corporation

Dan E. Payne, Former Chief of Security, CIA, current Chief Security Officer, ManTech International Corporation.

Downloads

Published

2022-03-25

How to Cite

Gittleman, J., Hasty, K., Schachter, S., & Payne, D. (2022). Health Data Security in Clinical R&D: An International Security Blindspot?. Global Biosecurity, 4(1). https://doi.org/10.31646/gbio.152

Issue

Vol. 4 (2022)

Section

Rapid Reports and Perspectives From the Field

License

Copyright (c) 2022 The Author(s)

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Authors who publish with this journal agree to the following terms:
  1. Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
  2. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
  3. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
Received 2022-01-18
Accepted 2022-01-31
Published 2022-03-25